InvestorsHub Logo
Followers 7
Posts 569
Boards Moderated 0
Alias Born 08/25/2012

Re: None

Monday, 10/01/2012 12:10:09 PM

Monday, October 01, 2012 12:10:09 PM

Post# of 24
ESMO - surprised at level of interest for pancreatic cancer

ESMO 2012: Abraxane in Pancreatic Cancer
A standing room audience at the 2012 European Society for Medical Oncology Congress in Vienna listened to a Celgene sponsored satellite symposia on Pancreatic Cancer.

...Update Sept 29: Abraxane data probably at ASCO GI meeting in early 2013

http://storify.com/3nt/esmo-2012-abraxane-in-pancreatic-cancer

Off label use will likely see a huge surge?